A p53 activator, haplo-insufficient tumor suppressor ASPP2, interacts with SREBP-2 and negatively regulates the mevalonate pathway to inhibit growth of HCC cells [79]. The gene discussed is SREBF2; the disease is hepatocellular carcinoma.